These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


109 related items for PubMed ID: 2674453

  • 21. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
    Armstrong RA, Lawrence RA, Jones RL, Wilson NH, Collier A.
    Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
    [Abstract] [Full Text] [Related]

  • 22. The in vitro and ex vivo antiplatelet effect of TRK-100, a stable prostacyclin analog, in several species.
    Nishio S, Matsuura H, Kanai N, Fukatsu Y, Hirano T, Nishikawa N, Kameoka K, Umetsu T.
    Jpn J Pharmacol; 1988 May; 47(1):1-10. PubMed ID: 2842529
    [Abstract] [Full Text] [Related]

  • 23. Cardiac electrophysiologic and antiarrhythmic actions of two long-acting spirobenzopyran piperidine class III agents, L-702,958 and L-706,000 [MK-499].
    Lynch JJ, Wallace AA, Stupienski RF, Baskin EP, Beare CM, Appleby SD, Salata JJ, Jurkiewicz NK, Sanguinetti MC, Stein RB.
    J Pharmacol Exp Ther; 1994 May; 269(2):541-54. PubMed ID: 7802864
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C, Bányász T, Magyar J, Gyönös I, Kovács A, Varró A, Szénási G, Nánási PP.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [Abstract] [Full Text] [Related]

  • 26. Influence of prostacyclin on coronary thrombosis and myocardial ischemia in conscious canine experiments.
    Fiedler VB, Mardin M.
    Arch Int Pharmacodyn Ther; 1985 Nov; 278(1):114-27. PubMed ID: 3913392
    [Abstract] [Full Text] [Related]

  • 27. The cardiovascular and platelet actions of 9 beta-methyl carbacyclin (ciprostene), a chemically stable analogue of prostacyclin, in the dog and monkey.
    Allan G, Follenfant MJ, Lidbury P, Oliver PL, Whittle BJ.
    Br J Pharmacol; 1985 Jun; 85(2):547-55. PubMed ID: 3896365
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effect of a stable prostacyclin analogue on platelet function and experimentally-induced thrombosis in the microcirculation.
    Sim AK, McCraw AP, Cleland ME, Nishio S, Umetsu T.
    Arzneimittelforschung; 1985 Jun; 35(12):1816-8. PubMed ID: 3913423
    [Abstract] [Full Text] [Related]

  • 31. Effects of prostacyclin on coronary circulation, heart rate and myocardial contractile force in isolated hearts of guinea pig and rabbit - comparison with prostaglandin E2.
    Schrör K, Moncada S.
    Prostaglandins; 1979 Mar; 17(3):367-73. PubMed ID: 382264
    [Abstract] [Full Text] [Related]

  • 32. Inhibition of post-ischemic ventricular recovery by low concentrations of prostacyclin in isolated working rat hearts: dependency on concentration, ischemia duration, calcium and relationship to myocardial energy metabolism.
    Karmazyn M, Neely JR.
    J Mol Cell Cardiol; 1989 Mar; 21(3):335-46. PubMed ID: 2664190
    [Abstract] [Full Text] [Related]

  • 33. Effects of prostacyclin (PGI2) on the smooth muscles of the guinea-pig stomach.
    Ishizawa M.
    Arch Int Pharmacodyn Ther; 1981 Sep; 253(1):80-9. PubMed ID: 7034665
    [Abstract] [Full Text] [Related]

  • 34. Electrophysiological effects of Org 7797 in the closed-chest anaesthetized dog.
    Leboeuf J, Basiez M, Massingham R.
    Br J Pharmacol; 1993 Sep; 110(1):23-8. PubMed ID: 8220882
    [Abstract] [Full Text] [Related]

  • 35. Prostaglandin I2 (PGI2) enhances calcium current in guinea-pig ventricular heart cells.
    Alloatti G, Serazzi L, Levi RC.
    J Mol Cell Cardiol; 1991 Jul; 23(7):851-60. PubMed ID: 1665186
    [Abstract] [Full Text] [Related]

  • 36. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
    Carmeliet E, Janssen PA, Marsboom R, Van Nueten JM, Xhonneux R.
    Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
    [Abstract] [Full Text] [Related]

  • 37. Bronchodilator effects of prostacyclin (PGI2) in dogs and guinea pigs.
    Wasserman MA, Ducharme DW, Wendling MG, Griffin RL, Degraaf GL.
    Eur J Pharmacol; 1980 Aug 22; 66(1):53-63. PubMed ID: 6997057
    [Abstract] [Full Text] [Related]

  • 38. Electrophysiological studies of penticainide (CM 7857), a new antiarrhythmic agent, in mammalian myocardium.
    Gautier P, Guiraudou P, Pezziardi F, Bertrand JP, Gagnol JP.
    J Cardiovasc Pharmacol; 1987 May 22; 9(5):601-10. PubMed ID: 2439843
    [Abstract] [Full Text] [Related]

  • 39. Myocardial biosynthesis of prostacyclin and the influence of cardiac loading and drugs.
    Mentz P, Pawelski KE, Giessler C, Mest HJ, Mannes F, Rotzoll S.
    Biomed Biochim Acta; 1988 May 22; 47(10-11):S244-7. PubMed ID: 3073764
    [Abstract] [Full Text] [Related]

  • 40. Direct effects of arsenic trioxide on action potentials in isolated cardiac tissues: importance of the choice of species, type of cardiac tissue and perfusion time.
    Lu HR, Vlaminckx E, Cools F, Gallacher DJ.
    J Pharmacol Toxicol Methods; 2012 Sep 22; 66(2):135-44. PubMed ID: 22445855
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.